Seeking Alpha reiterated a Buy rating for Oklo Inc. but lowered its price target to $88 from $99.
The reduction follows significant shareholder dilution from at-the-market equity offerings. These capital raises increased the company’s cash position to more than $3 billion.
Oklo achieved first criticality at its Groves test reactor in Texas in early August. This controlled, self-sustaining nuclear chain reaction occurred less than a year after the project broke ground.
Analysts cited strong operational execution during the second quarter of 2026 as the basis for the maintained positive outlook.